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Galectin-3 (Gal-3) is a pleiotropic lectin that has been rec-
ognized over the past two decades as being involved in many
physiological and pathological processes. Although the
galectin field has been a lot studied remain incompletely
understood, in particular the molecular mechanisms of their
actions in intra and extracellular space and the relationship
between these activities, as well as an associated regulatory
loop. Since it is well described that Gal-3 is widely distributed
both in the developing and mature bone and that its expres-
sion is under control of the master regulator of bone growth
RUNX2, it could suggest that Gal-3 may be a key player in all
stages of bone biology. Many types of bone pathologies are
strikingly related to severe damage inputs affecting the bone-
associated tissues. In particular, it is well recognized that
bone and muscle have recently been identified as endocrine
organs, that secrete cytokines and chemokines, through which
they interact to promote bone formation, repair and mainte-
nance in the bone-muscle cross talk. For that, the general aim
of our study is to define the role of Gal-3 on bone tissue and
its possible involvement in skeletal muscle crosstalk. First, we
found an increase of Gal- 3 expression during myogenic dif-
ferentiation and that it was secreted in the culture medium.
Through a coculture experiments between myogenic cells and
osteoblast cells we documented that recombinant Gal-3 inhib-
ited osteoblast differentiation and since it may be argued that
it may have a different conformation state in comparison to
endogenous Gal-3, we next tested whether the silencing of
Gal-3 secreted by muscle cells affect osteoblast differentiation
at the same manner. In order to investigate the effects induced
by extracellular Gal-3 on bone cells, focusing on signaling
events unleashed by the recombinant protein, by a mass spec-
trometric approach, we analyzed the entire proteome
obtained by differentiated osteoblasts differently affected by
the presence of recombinant Gal-3. Moreover, through an
ECM Cell Adhesion Array kit we monitored the impact of
Gal3 on the extracellular matrix complex, evaluating specific
cell surface Integrins and Adhesion molecules upon Gal-3
silencing, inhibition and overexpression. 
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Gravity is a well-known physical force that represents a
fascinating area of interest in biology and medicine, consid-
ering relevant physiological changes in organisms during
space exploration. Spaceflight opportunities are rare and
expensive and access to space experiments is limited, but
studies on the effect of gravity variation can be carried out
using devices able to simulate microgravity, like Random
Positioning Machine (RPM, Airbus, Defence & Space, ADS,
Dutch Space, Leiden, NL) used in ours experiments. The aim
of this project was to evaluate the effect of simulated weight-
lessness on human pancreatic adenocarcinoma cell line,
PaCa-44 (Neuroscience, Biomedicine and Movement depart-
ment, University of Verona). Pancreatic adenocarcinoma
remains a major unsolved health problem nowadays, with
conventional cancer treatments that have little impact on dis-
ease course. Pancreatic cancer co-opts multiple cellular and
extracellular mechanisms to create a complex cancer organ
with an unusual proclivity for metastasis and resistance to ther-
apy. Exploiting simulated microgravity (SM), we designed a
reproducible and easy method for scaffold-free PaCa-44
spheroids formation, that better reproduce the physical com-
munications and signaling pathways observed in firsts stages
of solid tumors. Morphological analyses were performed at
different time-points to evaluate cell’s aggregation and spher-
oid’s structure under SM. LC-MS/MS proteomics analyses
were performed on spheroids obtained by SM and on ground
control samples. Results showed variations in protein’s expres-
sion related to the process of epithelial mesenchymal transi-
tion (EMT) coupled with an increased glycolysis pathway
related to Warburg effect, typical in cancer cells, as con-
firmed by quantitative RT-PCR assay. Moreover, both proteom-
ic and PCR results showed an increase in expression levels of
genes and proteins related to stemness pathway in spheroids
samples compared to ground control non-spheroid cells. All
these data suggest that PaCa44 cells exposed to gravitational
unloading changed their growth behavior and started grow-
ing in a three dimensional (3D) manner in RPM. Moreover,
obtained data showed that simulated microgravity plays a
role in activation of molecular pathways implicated in stem-
ness and in overexpression of genes involved both in stemness
and in EMT under SMG condition, supporting the assumption
that microgravity induces cancer cell transformations towards
the acquisition of cancer stem cells-like features.
COMBINING TRANSLATION READTHROUGH
INDUCING DRUGS AND NONSENSE MEDIATED 
DECAY PATWHAY INHIBITION TO THE CFTR RESCUE
IN CYSTIC FIBROSIS CELL MODEL SYSTEM
Roberta BONGIORNO, Laura LENTINI, Andrea PACE,
Ivana PIBIRI
Dipartimento di Scienze e Tecnologie Biologiche, Chimiche e
Farmaceutiche (STEBICEF), Universita degli Studi di Palermo,
Italy
Nonsense mutations affect 10% of patients with cystic
fibrosis and produce a premature termination codon in CFTR
(Cystic Fibrosis Transmembrane Conductance Regulator)
mRNA causing early termination of translation and leading to
lack of CFTR function. A potential therapy for nonsense muta-
tions provides the use of small molecules able to overcome the
premature stop codon (PTC) by a readthrough mechanism that
lead to synthesis a complete CFTR protein. Despite the good
results obtained from this approach, TRIDs efficiency is consid-
erably reduced by the poor amount of target transcript, that is
the mRNA containing the PTC. The readthrough, indeed, does
not occur on the totality of target transcripts because of their
degradation due to the nonsense mediated decay pathway
(NMD). This pathway provides the degradation of mRNA har-
boring premature stop codon to prevent the production of
altered polypeptides. In contrast, the activity of this pathway
interferes with the effectiveness of the readthrough drugs, lim-
iting the mRNA concentration of the target protein. Thus, a
promising strategy for nonsense mutation treatment is a com-









bined use of readthrough agents and factors that attenuate the
nonsense mRNA decay. By silencing the UPF1 mRNA/pro-
tein, the activity of the NMD pathway was reduced, in FRT
cells CFTR W1282X. Alternatively, caffeine was used as specific
inhibitor of the UPF1 activity, to increase the efficiency of
readthrough molecules (NV848 and NV914) in FRT cells
CFTRW1282X cells. In both cases, the combined treatment:
NV848 or NV914/caffeine and NV848 or
NV914/UPF1siRNA caused an increase of CFTRW1282X
mRNA level followed by the rescue of the CFTR expression
and functionality. However, unexpectedly, despite the higher
CFTRW1282X mRNA level in caffeine treated samples, both
expression and functionality CFTR rescue resulted slightly
lower than the recovery achieved by UPF1 silencing. Our
results indicate that modulation of NMD pathway, although
still to be optimized, could be a promising approach in order
to increase TRIDs effects in presence of stop mutations. 
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Lipoproteins (LPs) are complex macromolecules, consist-
ing of a hydrophobic lipid core, rich in triglycerides and
cholesterol esters, surrounded by an envelope formed by
amphipathic molecules, such as phospholipids, non-esteri-
fied cholesterol and apolipoproteins. Plasma
lipoproteins are classified into five main classes: chylomi-
crons, VLDL (very low-density lipoprotein), IDL (intermediate-
density lipoprotein), LDL (low-density lipoprotein) and HDL
(high-density lipoprotein), based on their density and play a
key role in the transport lipids throughout the circulation.
Lipoprotein fractionation, as well as the quantification of the
amount of cholesterol and triglycerides carried by LPs, has
become one of the main clinical approaches to assess the
increased risk of cardiovascular complications in individu-
als. However, conventional lipidomics approaches used to
characterize LPs are notoriously laborious and extremely
time-consuming. In this context, Raman spectroscopy (RS)
represents an innovative, optical technique that allows to
analyze biological samples without any sample prepara-
tion. Moreover, this technique allows to obtain simultaneous
information about both the biomolecules composing lipopro-
teins and the relative amount. Therefore, the aim of the pres-
ent work is to demonstrate the suitability of RS to rapidly get
access to an impressive amount of valuable information
about the lipids and proteins of the main classes of LPs pres-
ent in blood – such as VLDL, LDL and HDL – thus providing
new tools that could be effectively used in clinic to perform
LPs analysis. We investigated spectra differences between
major lipoproteins classes isolated from plasma of six fast-
ing healthy donors, by ultracentrifugation in discontinuous
KBr density gradient. All spectra were acquired and ana-
lyzed in two different regions, the low frequency region
(between 400 and 1800 cm−1) and the high frequency
region (between 2600 and 3200 cm−1). The obtained spec-
tra showed peaks related to the different biomolecules that
compose the lipoproteins: cholesterol, triglycerides, mem-
brane lipids, unsaturated fatty acid, carotenoids, proteins,
and their intensity well reflects their relative composition.
Moreover, the typical structure of VLDL, LDL and HDL were
evaluated and confirmed by transmission electron
microscopy. Our preliminary results, obtained on a limited
number of subjects, suggesting that Raman spectroscopy
could be a viable and reproducible approach to provide a
biochemical signature of the main classes of LPs. Since the
composition of LPs is known to be altered in many patholog-
ical conditions, we are conducting a new study to demon-
strate the possible application of RS in diagnostics, in order
to identify the changes in lipoprotein composition.
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NOD-like receptor pyrin domain-containing 3 (NLRP3) is
the central component of the signalling complex “inflamma-
some” that promotes caspase-1 activation leading to pro-
cessing and release of IL-1β and IL-18. NLRP3 activation is
involved in different chronic age-related inflammatory dis-
eases, therefore selective inhibition of NLRP3 is a promising
strategy for the treatment of these diseases. The aim of this
project is the discovery of novel NLRP3 selective inhibitors
by using a semi-automated screening approach. To this pur-
pose a primary screening assay must be developed, minia-
turized and validated. Also, the development of an orthog-
onal assay is required for the validation of the primary
actives (compounds that give positive results in the primary
assay). Then, the real screening campaign can start. Herein
we present the results of the development and validation of
the primary and the orthogonal assays that will be used for
the screening campaign to find selective NLRP3 inhibitors. A
robust phenotypic primary assay was developed using
human THP-1 macrophages stimulated with lipopolysaccha-
ride (LPS) followed by nigericin, to induce selective activa-
tion of the NLRP3 inflammasome. At the end of the experi-
ments the release of IL-1β was measured using
Homogeneous Time-Resolved Fluorescence (HTRF) technolo-
gy. This primary assays was first tested and validated in 6-
well plates. The selective NLRP3 inhibitor MCC950 was
used as positive control and three additional reference com-
pounds, 3,4-methylenedioxy-β-nitrostyrene (MNS), partheno-
lide and glyburide, known to modulate NLRP3 activity, were
included in the assay. Herein we report half maximal
inhibitory concentration (IC50) and ICmax for MCC950 and
IC50 curves for the three reference compounds. We also
report the results of assay miniaturization in 384-well plates
and validation of the protocol using an automated liquid
handling system following a stringent statistical evaluation
of results reproducibility and variability. Finally, we present
the development of the orthogonal assay that allows to
measure NLRP3 activation using an independent approach
compared to primary assay in order to discriminate false
positives. The proposed orthogonal assay measures the
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